Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Product revenue $ 173 $ 437
Costs of revenue 151 364
Gross profit 22 73
Operating expenses:        
Research and development 869 549 2,557 2,383
General and administrative 714 654 2,166 2,912
Sales and marketing 139 303 42
Goodwill impairment 6,162 6,162
Total operating expenses 1,722 7,365 5,026 11,499
Loss from operations (1,700) (7,365) (4,953) (11,499)
Other income (expenses):        
Interest expense (1) (83) (3) (1,367)
Interest income 111 349
Change in fair value of derivative liabilities 144 4,480 754 6,500
Loss on extinguishment of debt (340)
Offering costs (682)
Loss on extinguishment of derivative liabilities (1,252)
Other income, net 1 48 6
Total other income, net 254 4,398 1,148 2,865
Net loss from continuing operations before income taxes (1,446) (2,967) (3,805) (8,634)
Provision for income taxes
Loss from continuing operations (1,446) (2,967) (3,805) (8,634)
Loss from discontinued operations (280) (324)
Net loss (1,446) (3,247) (3,805) (8,958)
Deemed dividend related to the beneficial conversion feature and accretion of a discount on series B preferred stock (345) (6,353) (2,703) (13,686)
Net loss attributable to common stockholders $ (1,791) $ (9,600) $ (6,508) $ (22,644)
Net loss per share - basic and diluted        
Basic - continuing operations $ (0.68) $ (7.09) $ (3.00) $ (35.45)
Basic - discontinued operations (0.67) (1.33)
Basic - deemed dividend and accretion of a discount on conversion of series B preferred stock (0.16) (15.17) (2.13) (56.20)
Basic - attributable to common stockholders (0.84) (22.93) (5.13) (92.98)
Diluted - continuing operations (0.75) (17.80) (3.59) (49.53)
Diluted - discontinued operations (0.67) (1.07)
Diluted - deemed dividend and accretion of a discount on conversion of series B preferred stock (0.16) (15.17) (2.13) (45.10)
Diluted - attributable to common stockholders $ (0.91) $ (33.64) $ (5.72) $ (95.70)
Weighted average common shares outstanding:        
Basic 2,127,293 418,638 1,269,106 243,543
Diluted 2,127,293 418,692 1,269,106 303,476